Published in J Viral Hepat on November 01, 2001
Real-time PCR in clinical microbiology: applications for routine laboratory testing. Clin Microbiol Rev (2006) 6.03
Methylation regulates hepatitis B viral protein expression. J Infect Dis (2009) 1.07
Comprehensive genetic and epigenetic analysis of occult hepatitis B from liver tissue samples. Clin Infect Dis (2008) 1.04
Fully automated, internally controlled quantification of hepatitis B Virus DNA by real-time PCR by use of the MagNA Pure LC and LightCycler instruments. J Clin Microbiol (2004) 1.00
Performance of the Cobas AmpliPrep/Cobas TaqMan real-time PCR assay for hepatitis B virus DNA quantification. J Clin Microbiol (2008) 1.00
Dynamic range and reproducibility of hepatitis B virus (HBV) DNA detection and quantification by Cobas Taqman HBV, a real-time semiautomated assay. J Clin Microbiol (2005) 0.98
Rapid quantification of hepatitis B virus DNA by real-time PCR using efficient TaqMan probe and extraction of virus DNA. World J Gastroenterol (2006) 0.92
Hepatitis B virus genotype E surface antigen detection with different immunoassays and diagnostic impact of mutations in the preS/S gene. Med Microbiol Immunol (2007) 0.91
Development of a new ultra sensitive real-time PCR assay (ultra sensitive RTQ-PCR) for the quantification of HBV-DNA. Virol J (2010) 0.88
Phage display creates innovative applications to combat hepatitis B virus. World J Gastroenterol (2014) 0.77
Establishment and assessment of two methods for quantitative detection of serum duck hepatitis B virus DNA. World J Gastroenterol (2004) 0.75
Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol (1992) 6.09
High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol (1999) 3.88
Hepatitis C virus antibodies among risk groups in Spain. Lancet (1989) 3.66
HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain. J Hepatol (2000) 3.66
Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med (1996) 3.60
Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care (2007) 3.54
Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med (1990) 2.50
The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (1)H-magnetic resonance abnormalities after liver transplantation. J Hepatol (2001) 2.42
Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Am J Gastroenterol (1999) 2.39
Sequence and analysis of the genetic locus responsible for surfactin synthesis in Bacillus subtilis. Mol Microbiol (1993) 2.35
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm. J Viral Hepat (2014) 2.23
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Portable encapsidation signal of the L-A double-stranded RNA virus of S. cerevisiae. Cell (1990) 2.00
Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg (2000) 2.00
Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells. Nature (1999) 1.99
Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. N Engl J Med (2000) 1.96
Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B. Lamivudine Precore Mutant Study Group. Hepatology (1999) 1.86
Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group. Headache (2001) 1.81
Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients. Am J Nephrol (1992) 1.77
In vitro L-A double-stranded RNA synthesis in virus-like particles from Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1986) 1.74
Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization. Ophthalmology (1999) 1.72
Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid raft clustering in T cells. J Cell Biol (2001) 1.70
Viral genotype and baseline load predict the response to adefovir treatment in lamivudine-resistant chronic hepatitis B patients. J Hepatol (2007) 1.68
Historical epidemiology of hepatitis C virus (HCV) in selected countries. J Viral Hepat (2014) 1.68
Strategies to manage hepatitis C virus (HCV) disease burden. J Viral Hepat (2014) 1.67
Risk of acute liver injury associated with the use of drugs: a multicentre population survey. Aliment Pharmacol Ther (2007) 1.55
Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C. J Hepatol (2000) 1.53
Adherence to antiviral drug regimens in HIV-infected adolescent patients engaged in care in a comprehensive adolescent and young adult clinic. J Natl Med Assoc (2000) 1.52
Phosphorus balance and mineral metabolism with 3 h daily hemodialysis. Kidney Int (2006) 1.51
Three different M1 RNA-containing viruslike particle types in Saccharomyces cerevisiae: in vitro M1 double-stranded RNA synthesis. Mol Cell Biol (1986) 1.47
Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders. Hepatology (2001) 1.45
Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy. Ann Trop Med Parasitol (1994) 1.42
Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology (2001) 1.41
A multicenter, randomized, double-blind study comparing once-daily bedtime administration of famotidine and ranitidine in the short-term treatment of active duodenal ulcer. Hepatogastroenterology (1989) 1.39
European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology (1999) 1.38
[Hepatocellular carcinoma: clinical aspects, diagnosis, and survival in 140 cases]. Med Clin (Barc) (1993) 1.38
[One year treatment with lamivudine in different hepatitis B virus related hepatic diseases]. Gastroenterol Hepatol (1999) 1.38
A multicenter, randomized, double-blind study comparing a daily bedtime administration of famotidine and ranitidine in short-term treatment of active duodenal ulcer. Digestion (1989) 1.38
Use of buccal fat pad to repair intraoral defects: review of 30 cases. Br J Oral Maxillofac Surg (1997) 1.37
Receiver operating characteristics curve analysis of factors predictive of nonresponse to interferon therapy in patients with chronic hepatitis C. Rev Esp Enferm Dig (2000) 1.37
Chronic delta hepatitis: detection of hepatitis delta virus antigen in serum by immunoblot and correlation with other markers of delta viral replication. Hepatology (1989) 1.37
Hands-on robotic unicompartmental knee replacement: a prospective, randomised controlled study of the acrobot system. J Bone Joint Surg Br (2006) 1.35
Hepatitis B virus infection: precore mutants and its relation to viral genotypes and core mutations. Hepatology (1995) 1.35
Dielectric antennas--a suitable platform for controlling magnetic dipolar emission. Opt Express (2012) 1.31
Dynamic behavior of hepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. J Virol (1994) 1.31
Cholesterol orientation and dynamics in dimyristoylphosphatidylcholine bilayers: a solid state deuterium NMR analysis. Biophys J (1999) 1.30
The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol (1996) 1.28
Diagnostic value of antikeratin antibodies in rheumatoid arthritis. J Rheumatol (1984) 1.27
Nucleotide and amino acid complexity of hepatitis C virus quasispecies in serum and liver. J Virol (2000) 1.23
Rapid detection of lamivudine-resistant hepatitis B virus polymerase gene variants. J Virol Methods (1999) 1.22
Development of a clinical hepatic encephalopathy staging scale. Aliment Pharmacol Ther (2007) 1.21
Release of oxytocin within the supraoptic nucleus during the milk ejection reflex in rats. Exp Brain Res (1989) 1.20
Targeting of lysosomal integral membrane protein LIMP II. The tyrosine-lacking carboxyl cytoplasmic tail of LIMP II is sufficient for direct targeting to lysosomes. J Biol Chem (1991) 1.19
An autologous oral DNA vaccine protects against murine melanoma. Proc Natl Acad Sci U S A (2000) 1.17
Hemoperitoneum as a first manifestation of hepatocellular carcinoma in western patients with liver cirrhosis: effectiveness of emergency treatment with transcatheter arterial embolization. Dig Dis Sci (2001) 1.17
In vitro susceptibility of Mycobacterium tuberculosis, Mycobacterium fortuitum and Mycobacterium chelonei to augmentin. Eur J Clin Microbiol (1986) 1.13
Hepatitis A and B in children and adolescents--what can we learn from Puglia (Italy) and Catalonia (Spain)? Vaccine (2000) 1.12
Antibacterial activity in blood cultures. J Clin Microbiol (1985) 1.12
Genetic analysis of hepatitis A virus strains recovered from the environment and from patients with acute hepatitis. J Gen Virol (2001) 1.11
Structure of replicating hepatitis C virus (HCV) quasispecies in the liver may not be reflected by analysis of circulating HCV virions. J Virol (1997) 1.11
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference. J Viral Hepat (2013) 1.10
Hepatitis E infection in acute sporadic hepatitis in Spain. Lancet (1993) 1.09
In vitro susceptibility of Mycobacterium avium to a new macrolide (RU-28965). Chemotherapy (1987) 1.07
Inhibition of thromboxane synthesis ameliorates the progressive kidney disease of rats with subtotal renal ablation. Proc Natl Acad Sci U S A (1985) 1.07